BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7356067)

  • 1. GABA levels in CSF of patients with psychiatric disorders.
    Gold BI; Bowers MB; Roth RH; Sweeney DW
    Am J Psychiatry; 1980 Mar; 137(3):362-4. PubMed ID: 7356067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa.
    Gerner RH; Hare TA
    Am J Psychiatry; 1981 Aug; 138(8):1098-101. PubMed ID: 7258390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
    Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N
    Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
    Orhan F; Fatouros-Bergman H; Goiny M; Malmqvist A; Piehl F; ; Cervenka S; Collste K; Victorsson P; Sellgren CM; Flyckt L; Erhardt S; Engberg G
    Mol Psychiatry; 2018 May; 23(5):1244-1250. PubMed ID: 28289277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls.
    Gerner RH; Fairbanks L; Anderson GM; Young JG; Scheinin M; Linnoila M; Hare TA; Shaywitz BA; Cohen DJ
    Am J Psychiatry; 1984 Dec; 141(12):1533-40. PubMed ID: 6209989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF levels of gamma-aminobutyric acid in schizophrenia. Low values in recently ill patients.
    van Kammen DP; Sternberg DE; Hare TA; Waters RN; Bunney WE
    Arch Gen Psychiatry; 1982 Jan; 39(1):91-7. PubMed ID: 7055411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of CSF somatostatin concentrations in mania.
    Sharma RP; Bissette G; Janicak PG; Davis JM; Nemeroff CB
    Am J Psychiatry; 1995 Dec; 152(12):1807-9. PubMed ID: 8526251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF GABA in depressed patients and normal controls.
    Roy A; Dejong J; Ferraro T
    Psychol Med; 1991 Aug; 21(3):613-8. PubMed ID: 1719577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF GABA in psychotic disorders.
    Bowers MB; Gold BI; Roth RH
    Psychopharmacology (Berl); 1980; 70(3):279-82. PubMed ID: 6777800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety in major depression and cerebrospinal fluid free gamma-aminobutyric acid.
    Mann JJ; Oquendo MA; Watson KT; Boldrini M; Malone KM; Ellis SP; Sullivan G; Cooper TB; Xie S; Currier D
    Depress Anxiety; 2014 Oct; 31(10):814-21. PubMed ID: 24865448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers.
    Naber D; Pickar D; Post RM; Van Kammen DP; Waters RN; Ballenger JC; Goodwin FK; Bunney WE
    Am J Psychiatry; 1981 Nov; 138(11):1457-62. PubMed ID: 6271019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive and practical RP-HPLC-FLD for determination of the low neuroactive amino acid levels in body fluids and its application in depression.
    Wu JL; Yu SY; Wu SH; Bao AM
    Neurosci Lett; 2016 Mar; 616():32-7. PubMed ID: 26808642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary studies on CSF gamma-aminobutyric acid levels in psychiatric patients before and during treatment with different psychotropic drugs.
    Zimmer R; Teelken AW; Meier KD; Ackenheil M; Zander KJ
    Prog Neuropsychopharmacol; 1980; 4(6):613-20. PubMed ID: 7220676
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebrospinal fluid GABA levels in chronic migraine with and without depression.
    Vieira DS; Naffah-Mazacoratti MG; Zukerman E; Senne Soares CA; Alonso EO; Faulhaber MH; Cavalheiro EA; Peres MF
    Brain Res; 2006 May; 1090(1):197-201. PubMed ID: 16638608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment.
    Lichtshtein D; Dobkin J; Ebstein RP; Biederman J; Rimon R; Belmaker RH
    Br J Psychiatry; 1978 Feb; 132():145-8. PubMed ID: 623945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of endorphins in CSF. Relationship to psychiatric diagnosis.
    Pickar D; Naber D; Post RM; van Kammen DP; Ballenger J; Kalin N; Bunney WE
    Mod Probl Pharmacopsychiatry; 1981; 17():246-62. PubMed ID: 7329420
    [No Abstract]   [Full Text] [Related]  

  • 17. CSF calcium: clinical correlates in affective illness and schizophrenia.
    Jimerson DC; Post RM; Carman JS; van Kammen DP; Wood JH; Goodwin FK; Bunney WE
    Biol Psychiatry; 1979 Feb; 14(1):37-51. PubMed ID: 420907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid gamma-aminobutyric acid in patients with panic disorder.
    Rimón R; Lepola U; Jolkkonen J; Halonen T; Riekkinen P
    Biol Psychiatry; 1995 Dec; 38(11):737-41. PubMed ID: 8580226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
    Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of central and peripheral γ-aminobutyric acid levels in patients with unipolar and bipolar depression.
    Romeo B; Choucha W; Fossati P; Rotge JY
    J Psychiatry Neurosci; 2018 Jan; 43(1):58-66. PubMed ID: 29252166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.